A clinician considering sermorelin needs to understand the treatments you already use. That includes prescription medicines, over-the-counter products, supplements, and other hormone-related therapies. An accurate list makes the conversation more useful than trying to remember everything during an intake.
This page is an organization guide, not an interaction checker. It does not decide whether a combination is safe, tell you to stop a medicine, or replace a pharmacist's review. Your prescribing professionals need to assess the actual products, doses, diagnoses, and circumstances.
This page is an organization guide, not an interaction checker. It does not decide whether a combination is safe, tell you to stop a medicine, or replace a pharmacist's review. Your prescribing professionals need to assess the actual products, doses, diagnoses, and circumstances.
Build the list from the labels
Record the product name, strength, amount you take, route, and schedule as written on the label. Include medicines used only occasionally. Add the reason for each treatment if you know it, along with the clinician who manages it. If a label is unclear, ask the pharmacy to explain it.
For supplements, photograph or bring the ingredient panel rather than relying only on the front-of-package name. Different versions of a similarly named product can contain different ingredients. Do not upload sensitive information to a general review-site search field; provide it through the clinician's intended secure process.
Add the history that changes the context
List relevant diagnoses, allergies, prior reactions, surgeries, and previous hormone treatments. The Strut safety information and IVY RX product information identify several histories that require discussion, including tumors or cancer, endocrine conditions, and glucose-related concerns.
Those provider pages are not complete eligibility rules for every patient. Tell the clinician about a condition even if it is not named on the form. Our safety guide provides general context and distinguishes medical risk from compounded-product quality questions.
Clarify who is coordinating care
If an existing specialist manages a condition, ask whether they should be involved before a new hormone-related prescription is considered. Confirm who will receive relevant results and who is responsible for interpreting them. Having more than one clinician is common; clear communication matters more than assuming each one has the same records.
A laboratory result should be considered with its date, reference range, and clinical context. The Endocrine Society guideline describes diagnosis as a process, not a conclusion supplied by a single online score. Read considering treatment after 50 for a broader preparation framework.
Ask about changes before making them
Do not stop, reduce, increase, or add an existing medicine to make a proposed sermorelin plan seem easier. Ask the relevant prescriber to resolve any change. If two sets of directions conflict, pause the decision and have the professionals clarify the intended plan.
If a prescription is issued, add the exact dispensed preparation to your list. Compounded products can differ in concentration and ingredients. The pharmacy checklist explains what to confirm on the label and how to reach the dispensing pharmacist.
Bring three written questions
Ask whether the proposed treatment changes the monitoring of anything you already take; which symptoms or results should prompt contact; and who is responsible for follow-up. Add those questions to your consultation checklist. A complete list supports a clinical discussion, while the final judgment remains with the qualified professionals who know your history.
The source notes
Sources & further reading
Provider pages document advertised offers, not independently proven outcomes. Historical references may concern different products or uses. Sources were checked for this edition on September 21, 2026; offers can change.